Trademark: 87199120
Word

Status
Registered
Status Code
702
Status Date
Friday, February 16, 2024
Serial Number
87199120
Registration Number
5298087
Registration Date
Tuesday, September 26, 2017
Mark Type
2000
Filing Date
Tuesday, October 11, 2016
Published for Opposition
Tuesday, December 20, 2016

Trademark Owner History
Regeneron Pharmaceuticals, Inc. - Original Registrant

Classifications
42 Scientific research in the field of genetics, genetic engineering, genetic sequencing, disease modeling, pharmacogenomics, and precision medicine
The mark consists of a double helix design composed of a series of circles in which one helix is the color orange and the other helix is the color blue.
The color(s) orange and blue is/are claimed as a feature of the mark.

Trademark Events
Feb 16, 2024
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Feb 16, 2024
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Feb 12, 2024
Case Assigned To Post Registration Paralegal
Aug 24, 2023
Teas Section 8 & 15 Received
Sep 26, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 14, 2022
Teas Change Of Correspondence Received
Jul 14, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 14, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 26, 2017
Registered-Principal Register
Aug 22, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 19, 2017
Allowed Principal Register - Sou Accepted
Aug 12, 2017
Statement Of Use Processing Complete
Jul 14, 2017
Use Amendment Filed
Aug 10, 2017
Case Assigned To Intent To Use Paralegal
Jul 14, 2017
Teas Statement Of Use Received
Feb 14, 2017
Noa E-Mailed - Sou Required From Applicant
Dec 20, 2016
Official Gazette Publication Confirmation E-Mailed
Dec 20, 2016
Published For Opposition
Nov 30, 2016
Notification Of Notice Of Publication E-Mailed
Nov 12, 2016
Approved For Pub - Principal Register
Nov 12, 2016
Assigned To Examiner
Oct 18, 2016
Notice Of Design Search Code E-Mailed
Oct 15, 2016
New Application Office Supplied Data Entered
Oct 14, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24